May 2025 – Launch of Phase III Clinical Trials with CAU

A large-scale, head-to-head clinical trial involving 50 diabetic cats and dogs began in partnership with CAU. The study compares Adapet CGM against leading global alternatives, measuring data stability, response lag time, user experience, and sensor endurance. This trial is expected to generate high-quality evidence for academic journals and regulatory filings in multiple markets.